These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 2464036)
1. Determination of epitope specificities and affinities of monoclonal antibodies in solution phase using biotin-labeled carcinoembryonic antigen and avidin as precipitating agent. Krüger U; Wickert L; Wagener C J Immunol Methods; 1989 Feb; 117(1):25-32. PubMed ID: 2464036 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: determination of affinities and specificities of monoclonal antibodies by using biotin-labeled antibodies and avidin as precipitating agent in a solution phase immunoassay. Wagener C; Clark BR; Rickard KJ; Shively JE J Immunol; 1983 May; 130(5):2302-7. PubMed ID: 6187848 [TBL] [Abstract][Full Text] [Related]
3. Use of biotin-labeled monoclonal antibodies and avidin-peroxidase conjugates for the determination of epitope specificities in a solid-phase competitive enzyme immunoassay. Wagener C; Fenger U; Clark BR; Shively JE J Immunol Methods; 1984 Mar; 68(1-2):269-74. PubMed ID: 6200540 [TBL] [Abstract][Full Text] [Related]
4. Selective precipitation of biotin-labeled antigens or monoclonal antibodies by avidin for determining epitope specificities and affinities in solution-phase assays. Wagener C; Krüger U; Shively JE Methods Enzymol; 1990; 184():518-29. PubMed ID: 1697026 [No Abstract] [Full Text] [Related]
5. Determination of epitope specificities of a large number of monoclonal antibodies by solid-phase mutual inhibition assays using biotinylated antigen. Kuroki M; Wakisaka M; Murakami M; Haruno M; Arakawa F; Higuchi H; Matsuoka Y Immunol Invest; 1992 Oct; 21(6):523-38. PubMed ID: 1385323 [TBL] [Abstract][Full Text] [Related]
6. Solution-phase RIA and solid-phase EIA using avidin-biotin systems for analysis of monoclonal antibody epitopes and affinity constants. Shively JE; Wagener C; Clark BR Methods Enzymol; 1986; 121():459-72. PubMed ID: 2425216 [No Abstract] [Full Text] [Related]
7. A solid-phase mutual inhibition assay with labeled antigen. Kuroki M Methods Mol Biol; 2009; 524():59-66. PubMed ID: 19377936 [TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: a systematic approach for the determination of epitope specificities of monoclonal antibodies. Wagener C; Yang YH; Crawford FG; Shively JE J Immunol; 1983 May; 130(5):2308-15. PubMed ID: 6187849 [TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies to carcinoembryonic antigen: a systematic analysis of antibody specificities by using related normal antigens and evidence for allotypic determinants on carcinoembryonic antigen. Kuroki M; Kuroki M; Koga Y; Matsuoka Y J Immunol; 1984 Oct; 133(4):2090-7. PubMed ID: 6206151 [TBL] [Abstract][Full Text] [Related]
10. Quantification of carcinoembryonic antigen in serum and analysis of epitope specificities of monoclonal antibodies. Wagener C; Wickert L; Shively JE Methods Enzymol; 1990; 184():507-18. PubMed ID: 1697025 [No Abstract] [Full Text] [Related]
11. Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids. Sutherland R; Buchegger F; Schreyer M; Vacca A; Mach JP Cancer Res; 1987 Mar; 47(6):1627-33. PubMed ID: 3545451 [TBL] [Abstract][Full Text] [Related]
12. Epitope group specificity of six immunoassays for carcinoembryonic antigen. Börmer OP; Thrane-Steen K Tumour Biol; 1991; 12(1):9-15. PubMed ID: 1705049 [TBL] [Abstract][Full Text] [Related]
13. Specificity of anti-carcinoembryonic antigen monoclonal antibodies and their effects on CEA-mediated adhesion. Zhou H; Stanners CP; Fuks A Cancer Res; 1993 Aug; 53(16):3817-22. PubMed ID: 7687926 [TBL] [Abstract][Full Text] [Related]
14. Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization. Casalini P; Luison E; Ménard S; Colnaghi MI; Paganelli G; Canevari S J Nucl Med; 1997 Sep; 38(9):1378-81. PubMed ID: 9293791 [TBL] [Abstract][Full Text] [Related]
15. Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice. Buchegger F; Haskell CM; Schreyer M; Scazziga BR; Randin S; Carrel S; Mach JP J Exp Med; 1983 Aug; 158(2):413-27. PubMed ID: 6886623 [TBL] [Abstract][Full Text] [Related]
16. Immunoradiometric assay of carcinoembryonic antigen with use of avidin-biotin labeling. Peters J; Schmidt-Gayk H; Peters B; Armbruster FP; Quentmeier A; Mathias D Clin Chem; 1989 Apr; 35(4):573-6. PubMed ID: 2649275 [TBL] [Abstract][Full Text] [Related]
18. Preparation, biodistribution, and dosimetry of 188Re-labeled MoAb ior cea1 and its F(ab')2 fragments by avidin-biotin strategy. Ferro-Flores G; Pimentel-González G; González-Zavala MA; Arteaga de Murphy C; Meléndez-Alafort L; Tendilla JI; Croft BY Nucl Med Biol; 1999 Jan; 26(1):57-62. PubMed ID: 10096502 [TBL] [Abstract][Full Text] [Related]
19. Limited improvement of tumour diagnosis by the simultaneous determination of carcinoembryonic antigen (CEA) and of a tumour-associated CEA-related antigen of Mr 128,000 in serum. Wagener C; Wickert L; Meyers W J Clin Chem Clin Biochem; 1989 Sep; 27(9):643-52. PubMed ID: 2691631 [TBL] [Abstract][Full Text] [Related]
20. Immunological heterogeneity of carcinoembryonic antigen: antigenic determinants on carcinoembryonic antigen distinguished by monoclonal antibodies. Primus FJ; Newell KD; Blue A; Goldenberg DM Cancer Res; 1983 Feb; 43(2):686-92. PubMed ID: 6184152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]